The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Brentuximub Vedoti Market Research Report 2025
Synopsis
Brentuximab vedotin is an antibody-drug conjugate medication used to treat relapsed or refractory Hodgkin lymphoma (HL) and systemic anaplastic large cell lymphoma (ALCL). It selectively targets tumor cells expressing the CD30 antigen, a defining marker of Hodgkin lymphoma and ALCL (a type of T cell non-Hodgkin lymphoma).
The global Brentuximub Vedoti market was valued at US$ 1481 million in 2023 and is anticipated to reach US$ 2353.6 million by 2030, witnessing a CAGR of 6.8% during the forecast period 2024-2030.
The Adcetris market is driven by the increasing prevalence of CD30-positive lymphomas, such as Hodgkin lymphoma and anaplastic large cell lymphoma. Adcetris, containing brentuximab vedotin, is an antibody-drug conjugate that specifically targets CD30-expressing cells, offering a highly targeted and effective treatment option for these lymphomas. The drug's approval and positive clinical outcomes have led to its growing adoption in lymphoma management. However, challenges include the high cost of the medication, potential side effects, and the need for continuous research to optimize treatment regimens and expand its use in other CD30-positive malignancies. Addressing these challenges through affordability measures, ongoing research, and patient access initiatives will be crucial for the sustained growth of the Adcetris market.
This report aims to provide a comprehensive presentation of the global market for Brentuximub Vedoti, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Brentuximub Vedoti.
Report Scope
The Brentuximub Vedoti market size, estimations, and forecasts are provided in terms of sales volume (K Unit) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Brentuximub Vedoti market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Brentuximub Vedoti manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Seagen
Takada
Segment by Type
Podwer
Liquid
Segment by Application
Hospital
Drugs Store
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Brentuximub Vedoti manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Brentuximub Vedoti in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Brentuximab vedotin is an antibody-drug conjugate medication used to treat relapsed or refractory Hodgkin lymphoma (HL) and systemic anaplastic large cell lymphoma (ALCL). It selectively targets tumor cells expressing the CD30 antigen, a defining marker of Hodgkin lymphoma and ALCL (a type of T cell non-Hodgkin lymphoma).
The global Brentuximub Vedoti market was valued at US$ 1481 million in 2023 and is anticipated to reach US$ 2353.6 million by 2030, witnessing a CAGR of 6.8% during the forecast period 2024-2030.
The Adcetris market is driven by the increasing prevalence of CD30-positive lymphomas, such as Hodgkin lymphoma and anaplastic large cell lymphoma. Adcetris, containing brentuximab vedotin, is an antibody-drug conjugate that specifically targets CD30-expressing cells, offering a highly targeted and effective treatment option for these lymphomas. The drug's approval and positive clinical outcomes have led to its growing adoption in lymphoma management. However, challenges include the high cost of the medication, potential side effects, and the need for continuous research to optimize treatment regimens and expand its use in other CD30-positive malignancies. Addressing these challenges through affordability measures, ongoing research, and patient access initiatives will be crucial for the sustained growth of the Adcetris market.
This report aims to provide a comprehensive presentation of the global market for Brentuximub Vedoti, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Brentuximub Vedoti.
Report Scope
The Brentuximub Vedoti market size, estimations, and forecasts are provided in terms of sales volume (K Unit) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Brentuximub Vedoti market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Brentuximub Vedoti manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Seagen
Takada
Segment by Type
Podwer
Liquid
Segment by Application
Hospital
Drugs Store
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Brentuximub Vedoti manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Brentuximub Vedoti in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Brentuximub Vedoti Market Overview
1.1 Product Overview and Scope of Brentuximub Vedoti
1.2 Brentuximub Vedoti Segment by Type
1.2.1 Global Brentuximub Vedoti Market Value Comparison by Type (2024-2030)
1.2.2 Podwer
1.2.3 Liquid
1.3 Brentuximub Vedoti Segment by Application
1.3.1 Global Brentuximub Vedoti Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Drugs Store
1.3.4 Other
1.4 Global Brentuximub Vedoti Market Size Estimates and Forecasts
1.4.1 Global Brentuximub Vedoti Revenue 2019-2030
1.4.2 Global Brentuximub Vedoti Sales 2019-2030
1.4.3 Global Brentuximub Vedoti Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Brentuximub Vedoti Market Competition by Manufacturers
2.1 Global Brentuximub Vedoti Sales Market Share by Manufacturers (2019-2024)
2.2 Global Brentuximub Vedoti Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Brentuximub Vedoti Average Price by Manufacturers (2019-2024)
2.4 Global Brentuximub Vedoti Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Brentuximub Vedoti, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Brentuximub Vedoti, Product Type & Application
2.7 Brentuximub Vedoti Market Competitive Situation and Trends
2.7.1 Brentuximub Vedoti Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Brentuximub Vedoti Players Market Share by Revenue
2.7.3 Global Brentuximub Vedoti Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Brentuximub Vedoti Retrospective Market Scenario by Region
3.1 Global Brentuximub Vedoti Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Brentuximub Vedoti Global Brentuximub Vedoti Sales by Region: 2019-2030
3.2.1 Global Brentuximub Vedoti Sales by Region: 2019-2024
3.2.2 Global Brentuximub Vedoti Sales by Region: 2025-2030
3.3 Global Brentuximub Vedoti Global Brentuximub Vedoti Revenue by Region: 2019-2030
3.3.1 Global Brentuximub Vedoti Revenue by Region: 2019-2024
3.3.2 Global Brentuximub Vedoti Revenue by Region: 2025-2030
3.4 North America Brentuximub Vedoti Market Facts & Figures by Country
3.4.1 North America Brentuximub Vedoti Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Brentuximub Vedoti Sales by Country (2019-2030)
3.4.3 North America Brentuximub Vedoti Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Brentuximub Vedoti Market Facts & Figures by Country
3.5.1 Europe Brentuximub Vedoti Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Brentuximub Vedoti Sales by Country (2019-2030)
3.5.3 Europe Brentuximub Vedoti Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Brentuximub Vedoti Market Facts & Figures by Country
3.6.1 Asia Pacific Brentuximub Vedoti Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Brentuximub Vedoti Sales by Country (2019-2030)
3.6.3 Asia Pacific Brentuximub Vedoti Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Brentuximub Vedoti Market Facts & Figures by Country
3.7.1 Latin America Brentuximub Vedoti Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Brentuximub Vedoti Sales by Country (2019-2030)
3.7.3 Latin America Brentuximub Vedoti Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Brentuximub Vedoti Market Facts & Figures by Country
3.8.1 Middle East and Africa Brentuximub Vedoti Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Brentuximub Vedoti Sales by Country (2019-2030)
3.8.3 Middle East and Africa Brentuximub Vedoti Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Brentuximub Vedoti Sales by Type (2019-2030)
4.1.1 Global Brentuximub Vedoti Sales by Type (2019-2024)
4.1.2 Global Brentuximub Vedoti Sales by Type (2025-2030)
4.1.3 Global Brentuximub Vedoti Sales Market Share by Type (2019-2030)
4.2 Global Brentuximub Vedoti Revenue by Type (2019-2030)
4.2.1 Global Brentuximub Vedoti Revenue by Type (2019-2024)
4.2.2 Global Brentuximub Vedoti Revenue by Type (2025-2030)
4.2.3 Global Brentuximub Vedoti Revenue Market Share by Type (2019-2030)
4.3 Global Brentuximub Vedoti Price by Type (2019-2030)
5 Segment by Application
5.1 Global Brentuximub Vedoti Sales by Application (2019-2030)
5.1.1 Global Brentuximub Vedoti Sales by Application (2019-2024)
5.1.2 Global Brentuximub Vedoti Sales by Application (2025-2030)
5.1.3 Global Brentuximub Vedoti Sales Market Share by Application (2019-2030)
5.2 Global Brentuximub Vedoti Revenue by Application (2019-2030)
5.2.1 Global Brentuximub Vedoti Revenue by Application (2019-2024)
5.2.2 Global Brentuximub Vedoti Revenue by Application (2025-2030)
5.2.3 Global Brentuximub Vedoti Revenue Market Share by Application (2019-2030)
5.3 Global Brentuximub Vedoti Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Seagen
6.1.1 Seagen Corporation Information
6.1.2 Seagen Description and Business Overview
6.1.3 Seagen Brentuximub Vedoti Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Seagen Brentuximub Vedoti Product Portfolio
6.1.5 Seagen Recent Developments/Updates
6.2 Takada
6.2.1 Takada Corporation Information
6.2.2 Takada Description and Business Overview
6.2.3 Takada Brentuximub Vedoti Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Takada Brentuximub Vedoti Product Portfolio
6.2.5 Takada Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Brentuximub Vedoti Industry Chain Analysis
7.2 Brentuximub Vedoti Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Brentuximub Vedoti Production Mode & Process
7.4 Brentuximub Vedoti Sales and Marketing
7.4.1 Brentuximub Vedoti Sales Channels
7.4.2 Brentuximub Vedoti Distributors
7.5 Brentuximub Vedoti Customers
8 Brentuximub Vedoti Market Dynamics
8.1 Brentuximub Vedoti Industry Trends
8.2 Brentuximub Vedoti Market Drivers
8.3 Brentuximub Vedoti Market Challenges
8.4 Brentuximub Vedoti Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
